We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 6,989

Indonesia - Newly enacted patent law provides clarity and takes steps toward harmonization
  • Bird & Bird
  • Indonesia
  • August 30 2016

Indonesia's new patent law came into effect on 28 August 2016. The country's earlier patent law, Law No. 14 enacted in 2001, had been in effect for


IPR Institution Denied Because Petitioner Used Hindsight Bias to Formulate Arguments
  • Marshall Gerstein & Borun LLP
  • USA
  • August 30 2016

On August 23, 2016, the PTAB denied Mylan Laboratories Limited's (Mylan) petition for IPR (IPR2016-00627) against a patent owned by Aventis Pharma S


In re: Magnum Oil Tools International
  • Winston & Strawn LLP
  • USA
  • August 29 2016

The Federal Circuit reversed the Patent Trial and Appeal Board’s (PTAB’s) finding of obviousness duringinter partes review (IPR) of a patent related


Medicines Company v. Hospira, Inc
  • Winston & Strawn LLP
  • USA
  • August 29 2016

The plaintiff, The Medicines Company (MedCo), sued in the District of Delaware alleging that the Defendant’s Abbreviated New Drug Application (ANDA


Amgen Inc. v. Apotex Inc
  • Winston & Strawn LLP
  • USA
  • August 29 2016

Amgen Inc. brought an action against Apotex Inc. under the Biologics Price Competition and Innovation Act (BPCIA) alleging that Apotex’s marketing of


German Federal Court of Justice Rules on Patent Infringement Under the Doctrine of Equivalents
  • Mayer Brown LLP
  • Germany
  • August 29 2016

On 14 June 2016, the German Federal Court of Justice (X ZR 2915 “Pemetrexed”) confirmed prior decisions in which it held that patent infringement


Experimental evidence in patent cases: Discovery not available for experiments on matters no longer in issue
  • Corrs Chambers Westgarth
  • Australia
  • August 26 2016

In patent cases, it is not uncommon to conduct preliminary experiments on a confidential and privileged basis prior to deciding whether or not to


Full Court warns against dangerous affliction of parameteritis (and confirms invalidity of aripiprazole patent)
  • King & Wood Mallesons
  • Australia
  • August 26 2016

On Wednesday the Full Court of the Federal Court of Australia handed down a decision in which it upheld Justice Yates' findings that Otsuka's patent


IPR and CBM Statistics for Final Written Decisions Issued in July 2016
  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • USA
  • August 26 2016

In the 35 Final Written Decisions issued by the Patent Trial and Appeal Board in July, the Board cancelled 412 (72.41) of the instituted claims and


Asserted claims are not anticipated but are obvious
  • Morris James LLP
  • USA
  • August 26 2016

The disputed technology relates to ethinyl estradiol and etonogestral vaginal Ring used for contraception. The bench trial took place from January 19